The problem that all large pharmaceuticals have now is they have no new products, no new blockbuster products that growth investors are looking for, ... It's looking even worse for '06-'07. So most of the potential now is coming from biotech.
More Quotes from Romeo Dator:
We're a little overbought and people are probably taking profits, ... A lot of the advance that we had was confirmation of the good news that we've gotten, and people are waiting for additional good news on that front.Romeo Dator
I don't see Cisco as a growth story right now.
Romeo Dator
Expectations on Wall Street got way ahead (of themselves).
Romeo Dator
Their first releases are always filled with bugs, so my guess is corporate users are going to take a long time to evaluate Vista before actually buying it.
Romeo Dator
The stock trade about 17.5 times 2003 earnings. That's at a premium compared with the other apparel companies out there but it's also growing faster than the other companies.
Romeo Dator
We're more or less waiting and seeing, ... Pfizer's dividend is definitely safe. It's the biggest drug company with good cash flow. It could easily buy a biotech company and improve their (research and development) line that way. That's what you're going to see with large-cap companies. They're going to partner up with biotech companies or buy them outright as a way to improve their (product) pipelines.
Romeo Dator
Readers Who Like This Quotation Also Like:
Based on Topics: Potential Quotes, Product QuotesI have designed the most buildings of any living American architect.
Alexander Jackson Davis
If I had my life to live over, I would perhaps have more actual troubles but I'd have fewer imaginary ones.
Don Herold